Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author Correction: Prospective...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Author Correction: Prospective de novo drug design with deep interactome learning

Author Correction: Prospective de novo drug design with deep interactome learning

Bibliographic Details
Main Authors: Kenneth Atz, Leandro Cotos, Clemens Isert, Maria Håkansson, Dorota Focht, Mattis Hilleke, David F. Nippa, Michael Iff, Jann Ledergerber, Carl C. G. Schiebroek, Valentina Romeo, Jan A. Hiss, Daniel Merk, Petra Schneider, Bernd Kuhn, Uwe Grether, Gisbert Schneider
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-55964-1
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1038/s41467-025-55964-1

Similar Items

  • Prospective de novo drug design with deep interactome learning
    by: Kenneth Atz, et al.
    Published: (2024-04-01)
  • Identifying opportunities for late-stage C-H alkylation with high-throughput experimentation and in silico reaction screening
    by: David F. Nippa, et al.
    Published: (2023-11-01)
  • QMugs, quantum mechanical properties of drug-like molecules
    by: Clemens Isert, et al.
    Published: (2022-06-01)
  • Domain Organization of Long Autotransporter Signal Sequences
    by: Jan A. Hiss, et al.
    Published: (2009-01-01)
  • Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
    by: Michael Moret, et al.
    Published: (2023-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs